« Back to Record
Rugo, H. H., Tolaney, S. S., Loirat, D., Punie, K., Bardia, A., Hurvitz, S., O'Shaughnessy, J., Cortes, J., Diéras, V., Carey, L. L., Gianni, L., Piccart-Gebhart, M., Loibl, S., Goldenberg, D. D., Hong, Q., Olivo, M. M., Itri, L. M., & Kalinsky, K. (2022). Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer. NPJ breast cancer, 8(1), 98. doi:10.1038/s41523-022-00467-1
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/350433



